May 14
|
PRESS DIGEST-British Business - May 14
|
May 13
|
UK pharma giants pledge £430m investment in France after Macron charm offensive
|
May 13
|
Update: AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study
|
May 13
|
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
|
May 13
|
France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit
|
May 12
|
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
|
May 10
|
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
|
May 10
|
Catalyst's New CEO Has Big Ideas For The Small Biotech
|
May 8
|
Update: AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents
|
May 8
|
Every household should be forced to have a smart meter, says British Gas boss
|
May 8
|
AstraZeneca withdraws Covid-19 vaccine, citing low demand
|
May 8
|
Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
|
May 8
|
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
|
May 8
|
AstraZeneca pulls its COVID-19 vaccine from the European market
|
May 8
|
AstraZeneca to withdraw Covid-19 vaccine globally
|
May 8
|
Q1 2024 Ionis Pharmaceuticals Inc Earnings Call
|
Jan 15
|
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca
|
Jan 12
|
Astrazeneca (AZN) Laps the Stock Market: Here's Why
|
Jan 12
|
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
|
Jan 11
|
Here's Why Astrazeneca (AZN) Fell More Than Broader Market
|